| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000036249 |
| Receipt No. | R000041287 |
| Scientific Title | Plant Fermented Food "Plant Fermented Extract Powder Z" Safety Confirmation Test |
| Date of disclosure of the study information | 2019/03/18 |
| Last modified on | 2019/03/18 (Ver. 1) |
| Basic information | ||
| Public title | Plant Fermented Food "Plant Fermented Extract Powder Z" Safety Confirmation Test | |
| Acronym | Plant Fermented Food "Plant Fermented Extract Powder Z" Safety Confirmation Test | |
| Scientific Title | Plant Fermented Food "Plant Fermented Extract Powder Z" Safety Confirmation Test | |
| Scientific Title:Acronym | Plant Fermented Food "Plant Fermented Extract Powder Z" Safety Confirmation Test | |
| Region |
|
|
| Condition | ||
| Condition | Healthy people | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Plant Fermented Extract Powder Z Ingest 3 times the daily intake to confirm the safety of the food. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Confirm the following offers from the subject: gastrointestinal disorder, vomiting, stomach discomfort, and feeling of fullness.
Confirm the influence on the liver and kidney by subject's blood test Subjects take the food for 28 days. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subject takes the food for 28 days. Ingest 1g a day, equivalent to three times the amount of active ingredient 300mg daily, for 28 days. Perform blood tests and questionnaires before and after the test. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)The person who does not take medicine for treatment.
2)The tendency to slight constipation (in a week 2-4 times) 3)The person who does not take bowel movement improvement medicine for examination one month. 4)The person who can do it constantly in live during the test days. 5)The person who was admitted by the judgment of the examination responsibility doctor. |
|||
| Key exclusion criteria | 1)The one with a serious disease.
2)person with a history of digestive disease and digestive surgery 3)The person who can not make life constant during examination 4) The person with allergy for the test food. 5)The person who is pregnant and hopes for the pregnancy during the examination. 6)The person who was not admitted by the judgment of the examination responsibility doctor. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Kagawa Nutrition University | ||||||
| Division name | Nutrition Clinic | ||||||
| Zip code | 170-8481 | ||||||
| Address | 3-24-3 Komagome,Toshima-ku, Tokyo. 170-8481 | ||||||
| TEL | 0339186181 | ||||||
| clinic@eiyo.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Kagawa Nutrition University | ||||||
| Division name | Nutrition Clinic | ||||||
| Zip code | 1708481 | ||||||
| Address | 3-24-3 Komagome,Toshima-ku, Tokyo. | ||||||
| TEL | 0339186181 | ||||||
| Homepage URL | |||||||
| kamachi@eiyo.ac.jp | |||||||
| Sponsor | |
| Institute | Kagawa Nutrition University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | International Food Co.Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kagawa Nutrition University |
| Address | 3-12-9 Chiyoda, Sakado-shi, Saitama |
| Tel | 0492832131 |
| clinic@eiyo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 20 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041287 |